-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $52

Benzinga·07/31/2026 19:36:54
语音播报
Citigroup analyst Samantha Semenkow maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $46 to $52.